501 related articles for article (PubMed ID: 21186264)
21. Clinical spectrum and gene mutations in a Chinese cohort with anoctaminopathy.
Cai S; Gao M; Xi J; Liu Z; Yue D; Wu H; Bi H; Li J; Liang Z; Zhao C; Udd B; Luo S; Lu J
Neuromuscul Disord; 2019 Aug; 29(8):628-633. PubMed ID: 31350120
[TBL] [Abstract][Full Text] [Related]
22. Anoctamin-5 related muscle disease: clinical and genetic findings in a large European cohort.
de Bruyn A; Montagnese F; Holm-Yildiz S; Scharff Poulsen N; Stojkovic T; Behin A; Palmio J; Jokela M; De Bleecker JL; de Visser M; van der Kooi AJ; Ten Dam L; Domínguez González C; Maggi L; Gallone A; Kostera-Pruszczyk A; Macias A; Łusakowska A; Nedkova V; Olive M; Álvarez-Velasco R; Wanschitz J; Paradas C; Mavillard F; Querin G; Fernández-Eulate G; Quinlivan R; Walter MC; Depuydt CE; Udd B; Vissing J; Schoser B; Claeys KG
Brain; 2023 Sep; 146(9):3800-3815. PubMed ID: 36913258
[TBL] [Abstract][Full Text] [Related]
23. Anoctamin 5 muscular dystrophy in Denmark: prevalence, genotypes, phenotypes, cardiac findings, and muscle protein expression.
Witting N; Duno M; Petri H; Krag T; Bundgaard H; Kober L; Vissing J
J Neurol; 2013 Aug; 260(8):2084-93. PubMed ID: 23670307
[TBL] [Abstract][Full Text] [Related]
24. Limb girdle muscular dystrophy type 2L presenting as necrotizing myopathy.
Schneider I; Stoltenburg G; Deschauer M; Winterholler M; Hanisch F
Acta Myol; 2014 May; 33(1):19-21. PubMed ID: 24843231
[TBL] [Abstract][Full Text] [Related]
25. Miyoshi-like distal myopathy with mutations in anoctamin 5 gene.
Bouquet F; Cossée M; Béhin A; Deburgrave N; Romero N; Leturcq F; Eymard B
Rev Neurol (Paris); 2012 Feb; 168(2):135-41. PubMed ID: 22336395
[TBL] [Abstract][Full Text] [Related]
26. ANO5-muscular dystrophy: clinical, pathological and molecular findings.
Liewluck T; Winder TL; Dimberg EL; Crum BA; Heppelmann CJ; Wang Y; Bergen HR; Milone M
Eur J Neurol; 2013 Oct; 20(10):1383-9. PubMed ID: 23663589
[TBL] [Abstract][Full Text] [Related]
27. Anoctamin 5 (ANO5) muscular dystrophy-three different phenotypes and a new histological pattern.
Seguí F; Gonzalez-Quereda L; Sanchez A; Matas-García A; Garrabou G; Rodriguez MJ; Gallano P; Grau JM; Milisenda JC
Neurol Sci; 2020 Oct; 41(10):2967-2971. PubMed ID: 32399949
[TBL] [Abstract][Full Text] [Related]
28. A novel ANO5 splicing variant in a LGMD2L patient leads to production of a truncated aggregation-prone Ano5 peptide.
Xu J; Xu L; Lau YS; Gao Y; Moore SA; Han R
J Pathol Clin Res; 2018 Apr; 4(2):135-145. PubMed ID: 29665321
[TBL] [Abstract][Full Text] [Related]
29. Next generation sequencing on patients with LGMD and nonspecific myopathies: Findings associated with ANO5 mutations.
Savarese M; Di Fruscio G; Tasca G; Ruggiero L; Janssens S; De Bleecker J; Delpech M; Musumeci O; Toscano A; Angelini C; Sacconi S; Santoro L; Ricci E; Claes K; Politano L; Nigro V
Neuromuscul Disord; 2015 Jul; 25(7):533-41. PubMed ID: 25891276
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic anoctamin-5 protein defect in patients with ANO5-mutated muscular dystrophy.
Vihola A; Luque H; Savarese M; Penttilä S; Lindfors M; Leturcq F; Eymard B; Tasca G; Brais B; Conte T; Charton K; Richard I; Udd B
Neuropathol Appl Neurobiol; 2018 Aug; 44(5):441-448. PubMed ID: 28489263
[TBL] [Abstract][Full Text] [Related]
31. Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I.
Boito CA; Melacini P; Vianello A; Prandini P; Gavassini BF; Bagattin A; Siciliano G; Angelini C; Pegoraro E
Arch Neurol; 2005 Dec; 62(12):1894-9. PubMed ID: 16344347
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.
Takahashi T; Aoki M; Suzuki N; Tateyama M; Yaginuma C; Sato H; Hayasaka M; Sugawara H; Ito M; Abe-Kondo E; Shimakura N; Ibi T; Kuru S; Wakayama T; Sobue G; Fujii N; Saito T; Matsumura T; Funakawa I; Mukai E; Kawanami T; Morita M; Yamazaki M; Hasegawa T; Shimizu J; Tsuji S; Kuzuhara S; Tanaka H; Yoshioka M; Konno H; Onodera H; Itoyama Y
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):433-40. PubMed ID: 23243261
[TBL] [Abstract][Full Text] [Related]
33. Sex differences in the involvement of skeletal and cardiac muscles in myopathic
Foltz S; Wu F; Ghazal N; Kwong JQ; Hartzell HC; Choo HJ
Am J Physiol Cell Physiol; 2022 Feb; 322(2):C283-C295. PubMed ID: 35020501
[TBL] [Abstract][Full Text] [Related]
34. Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures.
Mercuri E; Bushby K; Ricci E; Birchall D; Pane M; Kinali M; Allsop J; Nigro V; Sáenz A; Nascimbeni A; Fulizio L; Angelini C; Muntoni F
Neuromuscul Disord; 2005 Feb; 15(2):164-71. PubMed ID: 15694138
[TBL] [Abstract][Full Text] [Related]
35. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
[TBL] [Abstract][Full Text] [Related]
36. A founder mutation in the GMPPB gene [c.1000G > A (p.Asp334Asn)] causes a mild form of limb-girdle muscular dystrophy/congenital myasthenic syndrome (LGMD/CMS) in South Indian patients.
Polavarapu K; Mathur A; Joshi A; Nashi S; Preethish-Kumar V; Bardhan M; Sharma P; Parveen S; Seth M; Vengalil S; Chawla T; Shingavi L; Shamim U; Nayak S; Vivekanand A; Töpf A; Roos A; Horvath R; Lochmüller H; Nandeesh B; Arunachal G; Nalini A; Faruq M
Neurogenetics; 2021 Oct; 22(4):271-285. PubMed ID: 34333724
[TBL] [Abstract][Full Text] [Related]
37. Macular dystrophy presenting in one of two siblings with limb-girdle muscular dystrophy type 2L due to mutation of ANO5.
Vaz-Pereira S; Dansingani K; Holder GE; Webster AR
Eye (Lond); 2014 Jan; 28(1):102-4. PubMed ID: 24232312
[No Abstract] [Full Text] [Related]
38. New aspects on patients affected by dysferlin deficient muscular dystrophy.
Klinge L; Aboumousa A; Eagle M; Hudson J; Sarkozy A; Vita G; Charlton R; Roberts M; Straub V; Barresi R; Lochmüller H; Bushby K
J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):946-53. PubMed ID: 19528035
[TBL] [Abstract][Full Text] [Related]
39. Clinical and molecular findings in a cohort of ANO5-related myopathy.
Silva AMS; Coimbra-Neto AR; Souza PVS; Winckler PB; Gonçalves MVM; Cavalcanti EBU; Carvalho AADS; Sobreira CFDR; Camelo CG; Mendonça RDH; Estephan EDP; Reed UC; Machado-Costa MC; Dourado-Junior MET; Pereira VC; Cruzeiro MM; Helito PVP; Aivazoglou LU; Camargo LVD; Gomes HH; Camargo AJSD; Pinto WBVDR; Badia BML; Libardi LH; Yanagiura MT; Oliveira ASB; Nucci A; Saute JAM; França-Junior MC; Zanoteli E
Ann Clin Transl Neurol; 2019 Jul; 6(7):1225-1238. PubMed ID: 31353849
[TBL] [Abstract][Full Text] [Related]
40. Muscle MRI findings in limb girdle muscular dystrophy type 2L.
Sarkozy A; Deschauer M; Carlier RY; Schrank B; Seeger J; Walter MC; Schoser B; Reilich P; Leturq F; Radunovic A; Behin A; Laforet P; Eymard B; Schreiber H; Hicks D; Vaidya SS; Gläser D; Carlier PG; Bushby K; Lochmüller H; Straub V
Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S122-9. PubMed ID: 22980763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
